Skip to Main Content

1,488

Views

2

CrossRef citations to date

0

Altmetric

Research Paper

The irreversible ERBB1/2/4 inhibitor neratinib interacts with the PARP1 inhibitor niraparib to kill ovarian cancer cells

Laurence BoothDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USAView further author information

,

Jane L. RobertsDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USAView further author information

,

Peter SamuelDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USAView further author information

,

Francesca Avogadri-ConnorsPuma Biotechnology Inc., 1880 Wilshire Blvd, Los Angeles, CA, USAView further author information

,

Richard E. CutlerPuma Biotechnology Inc., 1880 Wilshire Blvd, Los Angeles, CA, USAView further author information

, Jr,

Alshad S. LalaniPuma Biotechnology Inc., 1880 Wilshire Blvd, Los Angeles, CA, USAView further author information

,

Andrew PoklepovicDepartment of Medicine, Virginia Commonwealth University, Richmond, VA, USAView further author information

&

Paul DentDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USACorrespondence[email protected]
View further author information